Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25840984.
- Also identified by DOI 10.1158/0008-5472.CAN-14-3076 and PMC identifier 4694051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Obesity has been linked to breast cancer progression but the underlying mechanisms remain obscure. Here we report how leptin, an obesity-associated adipokine, regulates a transcriptional pathway to silence a genetic program of epithelial homeostasis in breast cancer stem-like cells (CSC) that promotes malignant progression. Using genome-wide ChIP-seq and RNA expression profiling, we defined a role for activated STAT3 and G9a histone methyltransferase in epigenetic silencing of miR-200c, which promotes the formation of breast CSCs defined by elevated cell surface levels of the leptin receptor (OBR(hi)). Inhibiting the STAT3/G9a pathway restored expression of miR-200c, which in turn reversed the CSC phenotype to a more differentiated epithelial phenotype. In a rat model of breast cancer driven by diet-induced obesity, STAT3 blockade suppressed the CSC-like OBR(hi) population and abrogated tumor progression. Together, our results show how targeting STAT3-G9a signaling regulates CSC plasticity during obesity-related breast cancer progression, suggesting a novel therapeutic paradigm to suppress CSC pools and limit breast malignancy.
Medical subject headings
- Breast Neoplasms
- Histocompatibility Antigens
- Histone-Lysine N-Methyltransferase
- Leptin
- MicroRNAs
- Obesity
- STAT3 Transcription Factor